Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
44 hedge funds and large institutions have $164M invested in Alpine Immune Sciences Inc in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 6 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
38% more capital invested
Capital invested by funds: $119M → $164M (+$45M)
6% less funds holding
Funds holding: 47 → 44 (-3)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$14.6M |
| 2 |
O
OrbiMed
New York
|
+$9.31M |
| 3 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$6.86M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.03M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$3.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$7.37M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$4.75M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.7M |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.48M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.17M |
ALPN Hedge Fund Activity: Q3 2021 in Review
44 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q3 2021, worth a combined $164M — up 38% from $119M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ALPN and 4 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 18 added.
The largest buyer was BVF Inc, opening a new position worth an estimated $14.6M. The largest seller was Frazier Management, cutting an estimated $7.37M.
- 44 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q3 2021, down from 47 in Q2 2021.
- Funds reported $164M of Alpine Immune Sciences Inc stock for Q3 2021, up 38% quarter-over-quarter.
- 4 funds opened new Alpine Immune Sciences Inc positions in Q3 2021 and 6 closed out, a net change of -2 holders.
- The largest Alpine Immune Sciences Inc buyer in Q3 2021 was BVF Inc, an estimated $14.6M added.
- The largest Alpine Immune Sciences Inc seller in Q3 2021 was Frazier Management, an estimated $7.37M sold.
Based on aggregated 13F filings for Q3 2021.